• August 27, 2015

    CSAM's Synapse to Society: Addiction Medicine State of the Art 2015

  • August 24, 2015

    Editor's Comments

    This week signals the completion of a first step, in the evolution of the ASAM Weekly. Dr. Christian Schrader (MAJ, MC, USA) is the 2nd of the two University of Hawai`i addiction fellows to participate in the editorial vetting of this digest. We will continue to expand participation in the near future, happily enlisting Dr. Karen Miotto, Director of the Addictions Psychiatry Service at UCLA and members of her fellowship team.
  • August 20, 2015

    Thirteen Senators Stand Up for Increased Access to Addiction Treatment

    Thirteen US Senators wrote a letter to the Secretary of Health and Human Services Sylvia M. Burwell requesting that she use her authority to lift the cap on the number of patients with an opioid use disorder a physician can treat at one time.
  • August 17, 2015

    Editor's Comments

    This is the first edition in a pilot project for the ASAM Weekly, in which Addiction Psychiatry and Addiction Medicine fellows within training programs are provided the opportunity to review and comment on the articles provided. In this model, a senior faculty member such as the Editor reviews the work product, and further edits or augments the commentary as needed.
  • August 14, 2015

    Brain Stimulation as a Potential Treatment for Addiction

    Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.
  • August 14, 2015

    Join October Rally and Advocate for Addiction Solutions

    Be one of many coming to Washington, DC in a show of solidarity and collective force to help the 22 million Americans with addiction, support prevention for those not yet affected, stand up for the 23 million more in recovery, and urgently act to save the 350 lives lost each day
  • August 14, 2015

    Member Profile: Edwin Salsitz, MD, FASAM

    Dr. Salsitz has been involved in ASAM’s educational programs since 1998, when he took his first Review Course. As a result of his significant contributions to the field, he was named an ASAM Fellow in 2003 and received the ASAM Annual Award in 2014.
  • August 13, 2015

    Open Letter: Why I Helped Form a New Mexico ASAM Chapter

    My name is Dr. John R. Vigil, MD. I am the president of the newly chartered New Mexico Society of Addiction Medicine (NMSAM) and have been asked by ASAM to write why we started a state chapter in New Mexico.
  • August 13, 2015

    The Importance of Donating: One Family’s Story

    There are a myriad of reasons that can compel someone to donate to an organization. Ms. Joanne Krawczyk and Mr. Bill Keefe were not motivated to donate to the Ruth Fox Memorial Endowment because they are members of ASAM, or even because they are in the field, but they did so to honor their late son, Alex.
  • August 13, 2015

    Generals Always Fight the Last War

    The last war is prescription opioid abuse and addiction. The response has been to educate patients and doctors about appropriate prescribing and better management of pain through the use of non-medication alternatives. The new war is heroin.
  • August 13, 2015

    Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

    A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/AA, NA/therapist) are typically required as part of addiction treatment.
  • August 13, 2015

    Three Experts Join Journal of Addiction Medicine Editorial Team

    ASAM’s official journal recently welcomed the addition of three new statistical editors: Debbie Cheng, ScD, Charles Maynard, PhD, MSW, and Katie Witkiewitz, PhD. Together, the three editors will serve the important role of ensuring the high quality of research appearing in the society’s peer-reviewed journal.
  • August 13, 2015

    Member Profile: Merrill Herman, MD

    From 1995 until 2009, the New York Society of Addiction Medicine (NYSAM) grew and flourished under the hand of Dr. Merrill Herman.
  • August 11, 2015

    ASAM Members Speak on Boxed Warnings to FDA Advisory Committee

    On June 8 and 9, the FDA held a Risk Communication Advisory Committee (RCAC) Meeting to discuss the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine. ASAM members spoke about the need to preserve the access of pregnant women to addiction treatment.
  • August 11, 2015

    ASAM Testifies at FDA Meeting on Naloxone Uptake and Use

    ASAM member Dr. William Morrone recently spoke on ASAM's behalf about expanding access to the lifesaving medication naloxone.